Skip to main content
Equibles
PTGX $140.06 +0.63%
PTGX logo
PTGX · Protagonist Therapeutics, Inc
Track PTGX — free

Use PTGX with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research PTGX.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$140.06 +0.87 (+0.63%) At close · Oct 2
S&P 600 member Russell 2000 member Rebalance outlook locked
Market Cap
$9.18B
Shares
64.71M
Volume · Oct 2 760.3K Avg daily vol (3M) 634.39K
All webcasts

Earnings call · FY2025 Q2

Protagonist Therapeutics, Inc (PTGX) Q2 2025 Earnings Call

Concluded Aug 6, 2025
Aug 6, 2025 0 turns
Period
FY2025 Q2
Runtime
—
Sources
2 artifacts
8-K 10-Q

Executive readout · one minute

Webcast research workspace

Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.

Research coverage

2 live sources

Open each available source without leaving this research workspace.

Revenue $5.55M +33.1% YoY
Diluted EPS -$0.55
Net income -$34.77M

Research materials

Open the source you need; every reader stays inside this workspace.

8-K earnings release Filed Aug 6, 2025 10-Q report Filed Aug 6, 2025
Full-screen source Call document

PTGX transcript alerts

Protagonist Therapeutics, Inc

Create a free account or sign in to receive transcript alerts at your email address.

Continue to sign in
Read transcripts like this one from Claude, ChatGPT or your own code with the earnings call transcript API →